Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening
Author(s) -
Ahmedin Jemal,
MaryBeth B. Culp,
Jiemin Ma,
Farhad Islami,
Stacey A. Fedewa
Publication year - 2020
Publication title -
jnci journal of the national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.797
H-Index - 356
eISSN - 1460-2105
pISSN - 0027-8874
DOI - 10.1093/jnci/djaa068
Subject(s) - medicine , incidence (geometry) , demography , ethnic group , prostate cancer , gerontology , disease , cancer , physics , sociology , anthropology , optics
Previous studies reported that prostate cancer incidence rates in the United States declined for local-stage disease and increased for regional- and distant-stage disease following the US Preventive Services Task Force recommendations against prostate-specific antigen-based screening for men aged 75 years and older in 2008 and for all men in 2012. It is unknown, however, whether these patterns persisted through 2016.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom